Your browser doesn't support javascript.
loading
A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours.
Hong, David S; Kurzrock, Razelle; Mulay, Marilyn; Rasmussen, Erik; Wu, Benjamin M; Bass, Michael B; Zhong, Zhandong D; Friberg, Greg; Rosen, Lee S.
Afiliação
  • Hong DS; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77230-1402, USA.
  • Kurzrock R; Center for Personalized Cancer Therapy and CTO, Division of Hematology and Oncology, UC San Diego Moores Cancer Center, La Jolla, CA 92093-0658, USA.
  • Mulay M; Mulay Educational and Clinical Consulting Associates, Los Angeles, CA 90025, USA.
  • Rasmussen E; Department of Biostatistics, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Wu BM; Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Bass MB; Department of Molecular Sciences and Computational Biology, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Zhong ZD; Department of Clinical Immunology and Biological Sample Management, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Friberg G; Department of Early Development, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Rosen LS; Department of Medicine, Division of Hematology and Oncology, UCLA, Santa Monica, CA 90404, USA.
Oncotarget ; 5(22): 11154-67, 2014 Nov 30.
Article em En | MEDLINE | ID: mdl-25525888
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos